BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38648594)

  • 1. Depression As a Potential Contributing Factor in Hidradenitis Suppurativa and Associated Racial Gaps.
    Okwundu N; McMichael AJ
    Cutis; 2024 Mar; 113(3):137-140. PubMed ID: 38648594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pathogenesis and Treatment of Hidradenitis Suppurativa.
    Agnese ER; Tariche N; Sharma A; Gulati R
    Cureus; 2023 Nov; 15(11):e49390. PubMed ID: 38146560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence and odds of anxiety and depression in children and adults with hidradenitis suppurativa: Systematic review and meta-analysis.
    Jalenques I; Ciortianu L; Pereira B; D'Incan M; Lauron S; Rondepierre F
    J Am Acad Dermatol; 2020 Aug; 83(2):542-553. PubMed ID: 32222447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hidradenitis Suppurativa: Disease Burden and Etiology in Skin of Color.
    Lee DE; Clark AK; Shi VY
    Dermatology; 2017; 233(6):456-461. PubMed ID: 29495009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between hidradenitis suppurativa, depression, anxiety, and suicidality: A systematic review and meta-analysis.
    Patel KR; Lee HH; Rastogi S; Vakharia PP; Hua T; Chhiba K; Singam V; Silverberg JI
    J Am Acad Dermatol; 2020 Sep; 83(3):737-744. PubMed ID: 31862404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race-Specific Prevalence of Hidradenitis Suppurativa.
    Sachdeva M; Shah M; Alavi A
    J Cutan Med Surg; 2021; 25(2):177-187. PubMed ID: 33174482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Contributing to Depression and Chronic Pain in Patients with Hidradenitis Suppurativa: Results from a Single-Center Retrospective Review.
    Vangipuram R; Vaidya T; Jandarov R; Alikhan A
    Dermatology; 2016; 232(6):692-695. PubMed ID: 28068657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New-onset depression among children, adolescents, and adults with hidradenitis suppurativa.
    Wright S; Strunk A; Garg A
    J Am Acad Dermatol; 2020 Nov; 83(5):1360-1366. PubMed ID: 32446831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hidradenitis suppurativa.
    Sabat R; Jemec GBE; Matusiak Ł; Kimball AB; Prens E; Wolk K
    Nat Rev Dis Primers; 2020 Mar; 6(1):18. PubMed ID: 32165620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presentation of anxiety and depression among children and youth diagnosed with hidradenitis suppurativa: A review.
    Shojaei D; Liu C; Lam J
    Pediatr Dermatol; 2023; 40(6):983-989. PubMed ID: 37817294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa.
    Wright S; Strunk A; Garg A
    J Am Acad Dermatol; 2022 Jan; 86(1):55-60. PubMed ID: 34144081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidradenitis suppurativa.
    González-López MA
    Med Clin (Barc); 2024 Feb; 162(4):182-189. PubMed ID: 37968174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alexithymia, Psychological Distress, and Social Impairment in Patients with Hidradenitis Suppurativa.
    Quinto RM; Sampogna F; Fania L; Ciccone D; Fusari R; Mastroeni S; Iani L; Abeni D
    Dermatology; 2021; 237(1):103-110. PubMed ID: 31743903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System.
    Kokolakis G; Wolk K; Schneider-Burrus S; Kalus S; Barbus S; Gomis-Kleindienst S; Sabat R
    Dermatology; 2020; 236(5):421-430. PubMed ID: 32610312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yin and Yang: A disrupted skin microbiome and an aberrant host immune response in hidradenitis suppurativa.
    Schell SL; Schneider AM; Nelson AM
    Exp Dermatol; 2021 Oct; 30(10):1453-1470. PubMed ID: 34018644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging drugs for the treatment of hidradenitis suppurativa.
    Folkes AS; Hawatmeh FZ; Wong A; Kerdel FA
    Expert Opin Emerg Drugs; 2020 Sep; 25(3):201-211. PubMed ID: 32667213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on Hormonal Therapy in Hidradenitis Suppurativa.
    Karagaiah P; Daveluy S; Ortega-Loayza A; Gulliver W; Szepietowski J; Grabbe S; Goldust M
    J Drugs Dermatol; 2023 Apr; 22(4):369-374. PubMed ID: 37026880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis.
    Goldburg SR; Strober BE; Payette MJ
    J Am Acad Dermatol; 2020 May; 82(5):1045-1058. PubMed ID: 31604104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Mechanisms in Hidradenitis Suppurativa.
    Kelly G; Prens EP
    Dermatol Clin; 2016 Jan; 34(1):51-8. PubMed ID: 26617358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.